The International Neuromodulation Society 15th World Congress will feature over 470 abstracts and plenary lectures on neuromodulation therapy. Researchers from around the world will gather in Barcelona to discuss scientific theory and clinical applications of neuromodulation therapies.
Dr. Michael Stanton-Hicks is a pioneer in the management of complex regional pain syndrome (CRPS), with extensive contributions to neurostimulation and chronic pain research. He has bridged advances in neurostimulation, taxonomizing CRPS, and improved patient care through his work at the Cleveland Clinic.
Six abstracts selected for their innovative therapy approaches and basic research providing knowledge to improve treatment or clarify mode of action. These include a new functional treatment for chronic low back pain and stimulation effects on postural instability in Parkinson's disease.
Several emerging companies are developing innovative neuromodulation therapies to alleviate conditions such as autism spectrum disorder, spinal cord injury, and persistent pain. BioInduction Ltd.'s Picostim and BlueWind Medical's RENOVA iStim aim to provide targeted stimulation for various clinical indications.